| 000 | 01782 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516155642.0 | ||
| 264 | 0 | _c20140303 | |
| 008 | 201403s 0 0 eng d | ||
| 022 | _a1873-5967 | ||
| 024 | 7 |
_a10.1016/j.jcv.2013.05.009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aColson, Philippe | |
| 245 | 0 | 0 |
_aRelapse of hepatitis C virus after 14 months of sustained virological response following pegylated-interferon alpha plus ribavirin therapy in a human immunodeficiency virus type 1 infected patient. _h[electronic resource] |
| 260 |
_bJournal of clinical virology : the official publication of the Pan American Society for Clinical Virology _cSep 2013 |
||
| 300 |
_a309-14 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCluster Analysis |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHIV Infections _xcomplications |
| 650 | 0 | 4 |
_aHIV-1 _xisolation & purification |
| 650 | 0 | 4 |
_aHepacivirus _xclassification |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPhylogeny |
| 650 | 0 | 4 |
_aRNA, Viral _xgenetics |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aRibavirin _xtherapeutic use |
| 650 | 0 | 4 | _aSequence Analysis, DNA |
| 700 | 1 | _aBregigeon, Sylvie | |
| 700 | 1 | _aTourres, Christian | |
| 700 | 1 | _aSolas, Caroline | |
| 700 | 1 | _aPoizot-Martin, Isabelle | |
| 700 | 1 | _aTamalet, Catherine | |
| 773 | 0 |
_tJournal of clinical virology : the official publication of the Pan American Society for Clinical Virology _gvol. 58 _gno. 1 _gp. 309-14 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jcv.2013.05.009 _zAvailable from publisher's website |
| 999 |
_c22876159 _d22876159 |
||